Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Richard Gostanian. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att Richard Gostanian har rapporterat innehav eller affärer i följande företag:
Värdepapper | Titel | Senaste rapporterade innehav |
---|---|---|
US:BTAX / Biostax Corp. | 12 949 027 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Richard Gostanian. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderköp BTAX / Biostax Corp. - Analys av kortsiktig vinst
I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i BTAX / Biostax Corp.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderförsäljning - Analys av kortsiktig förlust
I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i BTAX / Biostax Corp.. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till min |
Pris vid min |
Maximal förlust undvikits ($) |
Maximal förlust undvikits ($) |
---|---|---|---|---|---|---|---|
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Richard Gostanian som avslöjats för Securities Exchange Commission (SEC).
Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 30 000 | 12 949 027 | 0,23 | 0,02 | 600 | 258 981 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 10 000 | 12 949 027 | 0,08 | 0,02 | 225 | 291 353 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 20 000 | 12 949 027 | 0,15 | 0,02 | 458 | 296 533 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 10 000 | 12 949 027 | 0,08 | 0,02 | 180 | 233 082 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 15 000 | 12 949 027 | 0,12 | 0,01 | 207 | 178 697 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 50 000 | 12 949 027 | 0,39 | 0,01 | 600 | 155 388 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 15 000 | 12 949 027 | 0,12 | 0,02 | 225 | 194 235 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 15 000 | 12 949 027 | 0,12 | 0,01 | 208 | 179 991 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 15 000 | 12 949 027 | 0,12 | 0,01 | 210 | 181 286 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 20 000 | 12 949 027 | 0,15 | 0,02 | 312 | 202 005 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 2 450 | 12 949 027 | 0,02 | 0,02 | 41 | 218 839 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 6 300 | 12 949 027 | 0,05 | 0,02 | 106 | 217 544 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 1 250 | 12 949 027 | 0,01 | 0,02 | 20 | 211 069 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 15 000 | 12 949 027 | 0,12 | 0,02 | 236 | 203 300 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 10 000 | 12 949 027 | 0,08 | 0,02 | 156 | 202 005 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 20 000 | 12 949 027 | 0,15 | 0,01 | 278 | 179 991 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 15 000 | 12 949 027 | 0,12 | 0,02 | 282 | 243 442 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 20 000 | 12 949 027 | 0,15 | 0,02 | 340 | 220 133 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 10 000 | 12 949 027 | 0,08 | 0,02 | 198 | 256 391 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 7 000 | 12 949 027 | 0,05 | 0,02 | 168 | 310 777 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 8 000 | 12 949 027 | 0,06 | 0,02 | 184 | 297 828 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 000 | 12 949 027 | 0,04 | 0,02 | 120 | 309 482 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 000 | 12 949 027 | 0,04 | 0,02 | 105 | 271 930 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 000 | 12 949 027 | 0,04 | 0,02 | 110 | 284 879 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 10 000 | 12 949 027 | 0,08 | 0,01 | 140 | 181 286 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 12 000 | 12 949 027 | 0,09 | 0,02 | 191 | 205 890 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 20 000 | 12 949 027 | 0,15 | 0,02 | 358 | 231 788 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 10 000 | 12 949 027 | 0,08 | 0,02 | 180 | 233 082 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 10 000 | 12 949 027 | 0,08 | 0,02 | 190 | 246 032 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 10 000 | 12 949 027 | 0,08 | 0,02 | 227 | 293 943 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 10 000 | 12 949 027 | 0,08 | 0,02 | 230 | 297 828 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 10 000 | 12 949 027 | 0,08 | 0,02 | 230 | 297 828 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 4 000 | 12 949 027 | 0,03 | 0,03 | 112 | 362 573 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 10 000 | 12 949 027 | 0,08 | 0,02 | 240 | 310 777 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 10 000 | 12 949 027 | 0,08 | 0,02 | 240 | 310 777 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 15 000 | 12 949 027 | 0,12 | 0,02 | 345 | 297 828 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 15 000 | 12 949 027 | 0,12 | 0,02 | 357 | 308 187 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 10 000 | 12 949 027 | 0,08 | 0,03 | 265 | 343 149 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 30 000 | 12 949 027 | 0,23 | 0,03 | 798 | 344 444 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 10 000 | 12 949 027 | 0,08 | 0,03 | 259 | 335 380 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 30 000 | 12 949 027 | 0,23 | 0,02 | 690 | 297 828 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 11 324 | 12 949 027 | 0,09 | 0,02 | 249 | 284 879 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 8 676 | 12 949 027 | 0,07 | 0,02 | 195 | 291 353 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 50 000 | 12 949 027 | 0,39 | 0,02 | 1 125 | 291 353 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 20 000 | 12 949 027 | 0,15 | 0,03 | 580 | 375 522 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 50 000 | 12 949 027 | 0,39 | 0,03 | 1 495 | 387 176 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 10 000 | 12 949 027 | 0,08 | 0,03 | 290 | 375 522 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 50 000 | 12 949 027 | 0,39 | 0,03 | 1 685 | 436 382 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 20 000 | 12 949 027 | 0,15 | 0,03 | 698 | 451 921 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 20 000 | 12 949 027 | 0,15 | 0,04 | 768 | 497 243 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 20 000 | 12 949 027 | 0,15 | 0,04 | 780 | 505 012 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 25 000 | 12 949 027 | 0,19 | 0,04 | 998 | 516 666 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 10 000 | 12 949 027 | 0,08 | 0,04 | 393 | 508 897 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 15 000 | 12 949 027 | 0,12 | 0,04 | 588 | 507 602 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 20 000 | 12 949 027 | 0,15 | 0,04 | 784 | 507 602 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 29 000 | 12 949 027 | 0,22 | 0,04 | 1 015 | 453 216 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 10 000 | 12 949 027 | 0,08 | 0,03 | 349 | 451 921 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 16 000 | 12 949 027 | 0,12 | 0,03 | 557 | 450 626 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 15 000 | 12 949 027 | 0,12 | 0,04 | 555 | 479 114 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 15 000 | 12 949 027 | 0,12 | 0,04 | 555 | 479 114 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 000 | 12 949 027 | 0,04 | 0,04 | 210 | 542 564 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 15 000 | 12 949 027 | 0,12 | 0,04 | 615 | 530 910 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 000 | 12 949 027 | 0,04 | 0,04 | 200 | 517 961 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 000 | 12 949 027 | 0,04 | 0,04 | 180 | 466 165 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 30 000 | 12 949 027 | 0,23 | 0,04 | 1 230 | 530 910 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 20 000 | 12 949 027 | 0,15 | 0,04 | 800 | 517 961 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 10 000 | 12 949 027 | 0,08 | 0,04 | 421 | 545 154 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 15 000 | 12 949 027 | 0,12 | 0,04 | 600 | 517 961 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 000 | 12 949 027 | 0,04 | 0,04 | 200 | 517 961 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 20 000 | 12 949 027 | 0,15 | 0,04 | 820 | 530 910 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 25 000 | 12 949 027 | 0,19 | 0,04 | 1 088 | 563 283 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 20 000 | 12 949 027 | 0,15 | 0,04 | 830 | 537 385 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 4 318 | 12 949 027 | 0,03 | 0,04 | 178 | 534 795 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 20 000 | 12 949 027 | 0,15 | 0,04 | 820 | 530 910 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 20 000 | 12 949 027 | 0,15 | 0,04 | 840 | 543 859 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 15 000 | 12 949 027 | 0,12 | 0,04 | 570 | 492 063 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 30 000 | 12 949 027 | 0,23 | 0,03 | 1 020 | 440 267 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 33 000 | 1 | −100,00 | 0,05 | 1 551 | 0 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 3 300 | 12 949 027 | 0,03 | 0,05 | 175 | 685 004 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 000 | 12 949 027 | 0,04 | 0,05 | 250 | 647 451 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 000 | 12 949 027 | 0,04 | 0,05 | 250 | 647 451 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 45 000 | 12 949 027 | 0,35 | 0,05 | 2 228 | 640 977 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 10 000 | 12 949 027 | 0,08 | 0,05 | 500 | 647 451 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 25 000 | 12 949 027 | 0,19 | 0,05 | 1 200 | 621 553 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 1 000 | 12 949 027 | 0,01 | 0,05 | 46 | 595 655 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 25 000 | 12 949 027 | 0,19 | 0,05 | 1 200 | 621 553 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 10 000 | 12 949 027 | 0,08 | 0,05 | 473 | 612 489 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 29 000 | 12 949 027 | 0,22 | 0,05 | 1 375 | 613 784 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 24 800 | 12 949 027 | 0,19 | 0,05 | 1 173 | 612 489 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 200 | 12 949 027 | 0,04 | 0,05 | 238 | 591 771 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 28 000 | 12 949 027 | 0,22 | 0,05 | 1 288 | 595 655 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 20 000 | 12 949 027 | 0,15 | 0,05 | 1 040 | 673 349 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 20 000 | 12 949 027 | 0,15 | 0,05 | 1 014 | 656 516 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 9 | 12 949 027 | 0,00 | 0,05 | 0 | 660 400 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 31 242 | 12 949 027 | 0,24 | 0,05 | 1 559 | 646 156 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 18 050 | 12 949 027 | 0,14 | 0,06 | 993 | 712 196 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 1 950 | 12 949 027 | 0,02 | 0,05 | 103 | 681 119 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 20 000 | 12 949 027 | 0,15 | 0,05 | 1 020 | 660 400 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 000 | 12 949 027 | 0,04 | 0,05 | 258 | 669 465 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 10 000 | 12 949 027 | 0,08 | 0,05 | 500 | 647 451 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 10 000 | 12 949 027 | 0,08 | 0,05 | 500 | 647 451 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 10 000 | 12 949 027 | 0,08 | 0,05 | 500 | 647 451 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 10 000 | 12 949 027 | 0,08 | 0,05 | 510 | 660 400 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 20 000 | 12 949 027 | 0,15 | 0,05 | 1 020 | 660 400 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 25 000 | 12 949 027 | 0,19 | 0,05 | 1 312 | 679 824 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 10 000 | 12 949 027 | 0,08 | 0,05 | 510 | 660 400 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 15 000 | 12 949 027 | 0,12 | 0,06 | 852 | 735 505 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 25 000 | 12 949 027 | 0,19 | 0,05 | 1 248 | 646 156 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 10 000 | 12 949 027 | 0,08 | 0,06 | 600 | 776 942 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 20 000 | 8 676 492 | 0,23 | 0,08 | 1 580 | 685 443 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 20 000 | 8 676 492 | 0,23 | 0,08 | 1 580 | 685 443 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 800 | 8 676 492 | 0,07 | 0,08 | 458 | 685 443 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 9 200 | 8 676 492 | 0,11 | 0,08 | 708 | 668 090 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 10 000 | 8 676 492 | 0,12 | 0,08 | 750 | 650 737 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 200 | 8 676 492 | 0,06 | 0,08 | 416 | 694 119 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 19 800 | 8 676 492 | 0,23 | 0,07 | 1 386 | 607 354 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 15 200 | 8 676 492 | 0,18 | 0,07 | 1 064 | 607 354 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 19 800 | 8 676 492 | 0,23 | 0,07 | 1 384 | 606 487 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 10 000 | 8 676 492 | 0,12 | 0,08 | 800 | 694 119 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 25 000 | 8 676 492 | 0,29 | 0,08 | 1 950 | 676 766 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 35 000 | 8 676 492 | 0,41 | 0,08 | 2 800 | 694 119 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 15 000 | 8 676 492 | 0,17 | 0,08 | 1 200 | 694 119 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 10 000 | 8 676 492 | 0,12 | 0,08 | 800 | 694 119 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 000 | 8 676 492 | 0,06 | 0,07 | 350 | 607 354 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 20 000 | 8 676 492 | 0,23 | 0,08 | 1 600 | 694 119 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 000 | 8 676 492 | 0,06 | 0,08 | 400 | 694 119 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 000 | 8 676 492 | 0,06 | 0,08 | 400 | 694 119 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 3 000 | 8 676 492 | 0,03 | 0,08 | 240 | 694 119 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 000 | 8 676 492 | 0,06 | 0,08 | 420 | 728 825 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 10 000 | 8 676 492 | 0,12 | 0,08 | 800 | 694 119 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 000 | 8 676 492 | 0,06 | 0,08 | 400 | 694 119 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 35 000 | 8 676 492 | 0,41 | 0,09 | 3 150 | 780 884 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 22 500 | 8 676 492 | 0,26 | 0,10 | 2 250 | 867 649 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 000 | 8 676 492 | 0,06 | 0,09 | 450 | 780 884 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 000 | 8 676 492 | 0,06 | 0,09 | 450 | 780 884 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 10 000 | 8 676 492 | 0,12 | 0,09 | 900 | 780 884 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 000 | 8 676 492 | 0,06 | 0,09 | 450 | 780 884 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 10 000 | 8 676 492 | 0,12 | 0,10 | 1 000 | 867 649 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 7 000 | 8 676 492 | 0,08 | 0,10 | 700 | 867 649 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 000 | 12 949 027 | 0,04 | 0,05 | 250 | 647 451 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 000 | 12 949 027 | 0,04 | 0,06 | 300 | 776 942 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 25 000 | 12 949 027 | 0,19 | 0,05 | 1 250 | 647 451 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 10 000 | 12 949 027 | 0,08 | 0,06 | 584 | 756 223 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 20 000 | 12 949 027 | 0,15 | 0,06 | 1 180 | 763 993 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 12 000 | 12 949 027 | 0,09 | 0,06 | 719 | 775 647 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 20 000 | 12 949 027 | 0,15 | 0,05 | 1 036 | 670 760 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 15 000 | 12 949 027 | 0,12 | 0,06 | 897 | 774 352 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 20 000 | 12 949 027 | 0,15 | 0,06 | 1 180 | 763 993 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 25 000 | 12 949 027 | 0,19 | 0,06 | 1 625 | 841 687 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 30 000 | 12 949 027 | 0,23 | 0,08 | 2 400 | 1 035 922 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 20 000 | 12 949 027 | 0,15 | 0,05 | 1 000 | 647 451 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 000 | 12 949 027 | 0,04 | 0,07 | 350 | 906 432 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 25 000 | 12 949 027 | 0,19 | 0,08 | 2 000 | 1 035 922 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 000 | 12 949 027 | 0,04 | 0,06 | 312 | 808 019 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 10 000 | 12 949 027 | 0,08 | 0,07 | 660 | 854 636 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 15 000 | 12 949 027 | 0,12 | 0,07 | 1 020 | 880 534 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 10 000 | 12 949 027 | 0,08 | 0,08 | 800 | 1 035 922 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 000 | 12 949 027 | 0,04 | 0,07 | 350 | 906 432 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 10 000 | 12 949 027 | 0,08 | 0,07 | 700 | 906 432 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 10 000 | 12 949 027 | 0,08 | 0,07 | 690 | 893 483 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 20 000 | 12 949 027 | 0,15 | 0,06 | 1 300 | 841 687 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 25 000 | 12 949 027 | 0,19 | 0,07 | 1 750 | 906 432 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 20 000 | 12 949 027 | 0,15 | 0,07 | 1 360 | 880 534 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 9 000 | 12 949 027 | 0,07 | 0,07 | 630 | 906 432 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 000 | 12 949 027 | 0,04 | 0,06 | 300 | 776 942 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 10 000 | 12 949 027 | 0,08 | 0,05 | 547 | 708 312 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 000 | 12 949 027 | 0,04 | 0,06 | 290 | 751 044 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 10 000 | 12 949 027 | 0,08 | 0,06 | 600 | 776 942 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 000 | 12 949 027 | 0,04 | 0,06 | 300 | 776 942 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 12 400 | 8 676 492 | 0,14 | 0,11 | 1 389 | 971 767 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 2 500 | 8 | −100,32 | 0,10 | 250 | 1 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 10 000 | 8 676 492 | 0,12 | 0,11 | 1 100 | 954 414 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 10 000 | 8 676 492 | 0,12 | 0,11 | 1 100 | 954 414 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 25 000 | 8 676 492 | 0,29 | 0,10 | 2 500 | 867 649 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 000 | 8 676 492 | 0,06 | 0,10 | 500 | 867 649 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 3 039 | 8 676 492 | 0,04 | 0,10 | 319 | 911 032 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 15 711 | 8 676 492 | 0,18 | 0,10 | 1 571 | 867 649 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 1 250 | 8 676 492 | 0,01 | 0,10 | 124 | 858 973 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 2 700 | 8 676 492 | 0,03 | 0,11 | 300 | 963 091 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 3 300 | 8 676 492 | 0,04 | 0,11 | 366 | 963 091 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 9 000 | 8 676 492 | 0,10 | 0,11 | 981 | 945 738 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 10 000 | 8 676 492 | 0,12 | 0,12 | 1 150 | 997 797 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 8 800 | 8 676 492 | 0,10 | 0,11 | 968 | 954 414 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 6 200 | 8 676 492 | 0,07 | 0,11 | 673 | 941 399 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 22 000 | 8 676 492 | 0,25 | 0,10 | 2 310 | 911 032 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 21 000 | 8 676 492 | 0,24 | 0,10 | 2 100 | 867 649 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 000 | 8 676 492 | 0,06 | 0,10 | 500 | 867 649 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 10 000 | 8 676 492 | 0,12 | 0,12 | 1 200 | 1 041 179 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 000 | 8 | −100,16 | 0,12 | 600 | 1 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 000 | 8 676 492 | 0,06 | 0,12 | 600 | 1 041 179 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 000 | 8 676 492 | 0,06 | 0,12 | 600 | 1 041 179 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 15 000 | 8 676 492 | 0,17 | 0,11 | 1 710 | 989 120 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 20 000 | 8 676 492 | 0,23 | 0,11 | 2 220 | 963 091 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 15 000 | 8 676 492 | 0,17 | 0,11 | 1 650 | 954 414 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 000 | 8 676 492 | 0,06 | 0,11 | 550 | 954 414 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 7 900 | 8 676 492 | 0,09 | 0,11 | 879 | 965 694 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 7 100 | 8 676 492 | 0,08 | 0,11 | 790 | 965 694 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 15 000 | 8 676 492 | 0,17 | 0,11 | 1 650 | 954 414 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 000 | 8 676 492 | 0,06 | 0,11 | 550 | 954 414 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 1 828 | 12 949 027 | 0,01 | 0,06 | 110 | 776 942 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 20 000 | 12 949 027 | 0,15 | 0,06 | 1 240 | 802 840 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 10 000 | 12 949 027 | 0,08 | 0,06 | 600 | 776 942 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 75 000 | 12 949 027 | 0,58 | 0,05 | 3 938 | 679 824 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 25 938 | 12 949 027 | 0,20 | 0,05 | 1 310 | 653 926 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 24 062 | 12 949 027 | 0,19 | 0,05 | 1 210 | 651 336 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 30 000 | 12 949 027 | 0,23 | 0,04 | 1 350 | 582 706 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 50 000 | 12 949 027 | 0,39 | 0,04 | 2 050 | 530 910 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 20 000 | 12 949 027 | 0,15 | 0,04 | 780 | 505 012 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 10 000 | 12 949 027 | 0,08 | 0,04 | 359 | 464 870 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 50 000 | 12 949 027 | 0,39 | 0,04 | 2 195 | 568 462 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 34 172 | 12 949 027 | 0,26 | 0,04 | 1 367 | 517 961 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 8 000 | 12 949 027 | 0,06 | 0,04 | 288 | 466 165 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 12 000 | 12 949 027 | 0,09 | 0,04 | 436 | 470 050 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 50 000 | 12 949 027 | 0,39 | 0,04 | 1 895 | 490 768 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 40 000 | 12 949 027 | 0,31 | 0,04 | 1 600 | 517 961 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 20 000 | 12 949 027 | 0,15 | 0,04 | 800 | 517 961 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 3 600 | 12 949 027 | 0,03 | 0,04 | 147 | 529 615 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 56 400 | 12 949 027 | 0,44 | 0,04 | 2 312 | 530 910 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 35 000 | 12 949 027 | 0,27 | 0,04 | 1 400 | 517 961 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 15 000 | 12 949 027 | 0,12 | 0,04 | 598 | 516 666 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 100 000 | 12 949 027 | 0,78 | 0,04 | 3 750 | 485 589 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 25 000 | 12 949 027 | 0,19 | 0,04 | 1 000 | 517 961 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 25 000 | 12 949 027 | 0,19 | 0,05 | 1 238 | 640 977 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 6 000 | 12 949 027 | 0,05 | 0,04 | 263 | 568 462 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 44 000 | 12 949 027 | 0,34 | 0,04 | 1 927 | 567 167 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 10 000 | 12 949 027 | 0,08 | 0,04 | 420 | 543 859 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 20 000 | 12 949 027 | 0,15 | 0,04 | 870 | 563 283 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 25 000 | 12 949 027 | 0,19 | 0,05 | 1 250 | 647 451 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 10 000 | 12 949 027 | 0,08 | 0,04 | 381 | 493 358 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 000 | 8 676 492 | 0,06 | 0,15 | 750 | 1 301 474 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 15 000 | 8 676 492 | 0,17 | 0,15 | 2 250 | 1 301 474 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 000 | 8 676 492 | 0,06 | 0,15 | 750 | 1 301 474 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 27 000 | 8 676 492 | 0,31 | 0,17 | 4 590 | 1 475 004 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 000 | 8 676 492 | 0,06 | 0,17 | 850 | 1 475 004 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 000 | 8 676 492 | 0,06 | 0,17 | 850 | 1 475 004 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 000 | 8 676 492 | 0,06 | 0,17 | 850 | 1 475 004 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 000 | 8 676 492 | 0,06 | 0,18 | 900 | 1 561 769 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 000 | 8 676 492 | 0,06 | 0,18 | 900 | 1 561 769 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 000 | 8 676 492 | 0,06 | 0,18 | 900 | 1 561 769 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 000 | 8 676 492 | 0,06 | 0,18 | 875 | 1 518 386 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 15 000 | 8 676 492 | 0,17 | 0,18 | 2 700 | 1 561 769 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 000 | 8 676 492 | 0,06 | 0,17 | 850 | 1 475 004 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 3 750 | 8 676 492 | 0,04 | 0,17 | 638 | 1 475 004 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 1 250 | 8 676 492 | 0,01 | 0,16 | 200 | 1 388 239 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 6 500 | 8 676 492 | 0,07 | 0,17 | 1 112 | 1 483 680 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 000 | 8 676 492 | 0,06 | 0,17 | 850 | 1 475 004 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 000 | 8 676 492 | 0,06 | 0,16 | 800 | 1 388 239 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 10 000 | 8 676 492 | 0,12 | 0,17 | 1 700 | 1 475 004 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 000 | 8 676 492 | 0,06 | 0,16 | 800 | 1 388 239 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 7 044 | 8 676 492 | 0,08 | 0,17 | 1 197 | 1 475 004 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 4 956 | 8 676 492 | 0,06 | 0,17 | 843 | 1 475 004 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 2 267 | 8 676 492 | 0,03 | 0,18 | 408 | 1 561 769 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 2 733 | 8 676 492 | 0,03 | 0,18 | 492 | 1 561 769 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 583 | 8 676 492 | 0,01 | 0,18 | 108 | 1 605 151 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 000 | 8 676 492 | 0,06 | 0,18 | 925 | 1 605 151 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 9 417 | 8 676 492 | 0,11 | 0,18 | 1 742 | 1 605 151 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 000 | 8 676 492 | 0,06 | 0,18 | 920 | 1 596 475 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 000 | 8 676 492 | 0,06 | 0,18 | 920 | 1 596 475 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 10 000 | 8 676 492 | 0,12 | 0,19 | 1 900 | 1 648 533 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 35 000 | 12 949 027 | 0,27 | 0,04 | 1 400 | 517 961 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 65 000 | 12 949 027 | 0,50 | 0,03 | 2 178 | 433 792 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 10 000 | 12 949 027 | 0,08 | 0,03 | 330 | 427 318 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 55 000 | 12 949 027 | 0,43 | 0,03 | 1 705 | 401 420 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 40 000 | 12 949 027 | 0,31 | 0,03 | 1 200 | 388 471 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 100 000 | 12 949 027 | 0,78 | 0,03 | 3 250 | 420 843 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 000 | 12 949 027 | 0,04 | 0,04 | 200 | 517 961 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 105 000 | 12 949 027 | 0,82 | 0,04 | 4 200 | 517 961 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 000 | 12 949 027 | 0,04 | 0,04 | 200 | 517 961 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 20 000 | 12 949 027 | 0,15 | 0,05 | 1 000 | 647 451 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 35 000 | 12 949 027 | 0,27 | 0,05 | 1 750 | 647 451 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 000 | 12 949 027 | 0,04 | 0,04 | 200 | 517 961 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 29 200 | 12 949 027 | 0,23 | 0,05 | 1 460 | 647 451 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 115 000 | 12 949 027 | 0,90 | 0,05 | 5 750 | 647 451 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 000 | 12 949 027 | 0,04 | 0,05 | 250 | 647 451 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 252 800 | 12 949 027 | 1,99 | 0,05 | 12 640 | 647 451 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 000 | 12 949 027 | 0,04 | 0,05 | 250 | 647 451 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 40 000 | 12 949 027 | 0,31 | 0,06 | 2 400 | 776 942 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 30 000 | 12 949 027 | 0,23 | 0,07 | 2 100 | 906 432 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 50 000 | 12 949 027 | 0,39 | 0,07 | 3 500 | 906 432 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 15 000 | 12 949 027 | 0,12 | 0,07 | 1 050 | 906 432 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 10 217 | 12 949 027 | 0,08 | 0,07 | 755 | 956 933 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 10 000 | 12 949 027 | 0,08 | 0,07 | 700 | 906 432 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 10 000 | 12 949 027 | 0,08 | 0,07 | 700 | 906 432 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 10 000 | 12 949 027 | 0,08 | 0,08 | 800 | 1 035 922 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 20 000 | 12 949 027 | 0,15 | 0,05 | 1 098 | 710 902 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 10 000 | 12 949 027 | 0,08 | 0,06 | 590 | 763 993 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 25 000 | 12 949 027 | 0,19 | 0,05 | 1 300 | 673 349 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 6 500 | 12 949 027 | 0,05 | 0,05 | 318 | 633 207 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 3 500 | 12 949 027 | 0,03 | 0,05 | 169 | 625 438 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 2 000 | 12 949 027 | 0,02 | 0,04 | 90 | 582 706 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 10 000 | 12 949 027 | 0,08 | 0,04 | 449 | 581 411 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 22 000 | 12 949 027 | 0,17 | 0,05 | 1 144 | 673 349 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 10 000 | 8 676 492 | 0,12 | 0,06 | 600 | 520 590 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 25 000 | 8 676 492 | 0,29 | 0,05 | 1 250 | 433 825 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 10 000 | 8 676 492 | 0,12 | 0,05 | 500 | 433 825 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 25 000 | 8 676 492 | 0,29 | 0,05 | 1 250 | 433 825 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 000 | 8 676 492 | 0,06 | 0,05 | 250 | 433 825 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 10 000 | 8 676 492 | 0,12 | 0,07 | 700 | 607 354 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 10 000 | 8 676 492 | 0,12 | 0,08 | 780 | 676 766 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 25 000 | 8 | −100,03 | 0,06 | 1 598 | 1 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 25 000 | 8 676 492 | 0,29 | 0,06 | 1 585 | 550 090 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 000 | 8 676 492 | 0,06 | 0,06 | 300 | 520 590 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 000 | 8 676 492 | 0,06 | 0,06 | 311 | 539 678 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 000 | 8 676 492 | 0,06 | 0,06 | 300 | 520 590 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 15 000 | 8 676 492 | 0,17 | 0,06 | 900 | 520 590 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 000 | 8 676 492 | 0,06 | 0,08 | 400 | 694 119 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 000 | 8 676 492 | 0,06 | 0,08 | 400 | 694 119 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 25 000 | 8 676 492 | 0,29 | 0,08 | 2 000 | 694 119 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 000 | 8 676 492 | 0,06 | 0,08 | 400 | 694 119 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 20 000 | 8 676 492 | 0,23 | 0,07 | 1 400 | 607 354 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 000 | 8 676 492 | 0,06 | 0,07 | 350 | 607 354 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 20 000 | 8 676 492 | 0,23 | 0,07 | 1 400 | 607 354 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 25 000 | 8 676 492 | 0,29 | 0,07 | 1 750 | 607 354 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 000 | 8 676 492 | 0,06 | 0,07 | 357 | 619 502 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 20 000 | 8 676 492 | 0,23 | 0,07 | 1 420 | 616 031 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 25 000 | 8 | −100,03 | 0,08 | 2 000 | 1 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 15 000 | 8 | −100,05 | 0,09 | 1 350 | 1 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 000 | 8 676 492 | 0,06 | 0,08 | 400 | 694 119 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 000 | 8 676 492 | 0,06 | 0,08 | 400 | 694 119 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 000 | 8 676 492 | 0,06 | 0,10 | 500 | 867 649 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 000 | 8 676 492 | 0,06 | 0,09 | 450 | 780 884 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 10 100 | 8 676 492 | 0,12 | 0,10 | 1 010 | 867 649 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 000 | 8 676 492 | 0,06 | 0,10 | 500 | 867 649 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 900 | 8 676 492 | 0,01 | 0,10 | 90 | 867 649 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 10 000 | 8 676 492 | 0,12 | 0,10 | 1 000 | 867 649 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 000 | 8 676 492 | 0,06 | 0,10 | 500 | 867 649 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 000 | 8 676 492 | 0,06 | 0,10 | 500 | 867 649 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 25 000 | 8 676 492 | 0,29 | 0,10 | 2 500 | 867 649 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 000 | 8 676 492 | 0,06 | 0,10 | 500 | 867 649 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 15 000 | 8 676 492 | 0,17 | 0,10 | 1 500 | 867 649 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 000 | 8 676 492 | 0,06 | 0,10 | 500 | 867 649 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 12 000 | 8 676 492 | 0,14 | 0,11 | 1 320 | 954 414 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 20 000 | 8 676 492 | 0,23 | 0,11 | 2 200 | 954 414 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 15 000 | 8 676 492 | 0,17 | 0,11 | 1 650 | 954 414 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 13 100 | 8 676 492 | 0,15 | 0,11 | 1 441 | 954 414 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 000 | 8 676 492 | 0,06 | 0,11 | 550 | 954 414 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 000 | 8 676 492 | 0,06 | 0,10 | 500 | 867 649 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 1 900 | 8 676 492 | 0,02 | 0,11 | 209 | 954 414 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 000 | 8 676 492 | 0,06 | 0,11 | 550 | 954 414 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 15 000 | 8 676 492 | 0,17 | 0,11 | 1 650 | 954 414 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 000 | 8 676 492 | 0,06 | 0,11 | 550 | 954 414 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 20 000 | 8 676 492 | 0,23 | 0,11 | 2 200 | 954 414 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 000 | 8 676 492 | 0,06 | 0,11 | 550 | 954 414 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 7 864 | 8 676 492 | 0,09 | 0,10 | 786 | 867 649 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 000 | 8 676 492 | 0,06 | 0,10 | 500 | 867 649 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 000 | 8 676 492 | 0,06 | 0,11 | 550 | 954 414 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 1 000 | 8 676 492 | 0,01 | 0,11 | 110 | 954 414 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 1 783 | 8 676 492 | 0,02 | 0,12 | 210 | 1 023 826 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 100 | 8 676 492 | 0,06 | 0,11 | 571 | 971 767 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 12 000 | 8 676 492 | 0,14 | 0,12 | 1 440 | 1 041 179 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 14 816 | 8 676 492 | 0,17 | 0,12 | 1 748 | 1 023 826 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 20 000 | 8 676 492 | 0,23 | 0,11 | 2 258 | 979 576 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 000 | 8 676 492 | 0,06 | 0,11 | 564 | 979 576 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 000 | 8 676 492 | 0,06 | 0,11 | 564 | 979 576 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 10 000 | 8 676 492 | 0,12 | 0,11 | 1 129 | 979 576 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 000 | 8 676 492 | 0,06 | 0,11 | 545 | 945 738 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 50 184 | 8 676 492 | 0,58 | 0,11 | 5 470 | 945 738 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 20 000 | 8 676 492 | 0,23 | 0,12 | 2 400 | 1 041 179 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 000 | 8 676 492 | 0,06 | 0,12 | 600 | 1 041 179 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 000 | 8 676 492 | 0,06 | 0,11 | 550 | 954 414 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 20 000 | 8 676 492 | 0,23 | 0,12 | 2 400 | 1 041 179 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 000 | 8 676 492 | 0,06 | 0,12 | 600 | 1 041 179 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 000 | 8 676 492 | 0,06 | 0,12 | 600 | 1 041 179 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 000 | 8 | −100,16 | 0,12 | 600 | 1 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 000 | 8 676 492 | 0,06 | 0,13 | 650 | 1 127 944 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 000 | 8 676 492 | 0,06 | 0,12 | 600 | 1 041 179 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 000 | 8 676 492 | 0,06 | 0,13 | 650 | 1 127 944 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 000 | 8 676 492 | 0,06 | 0,13 | 650 | 1 127 944 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 25 000 | 8 676 492 | 0,29 | 0,12 | 3 125 | 1 084 562 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 000 | 8 676 492 | 0,06 | 0,12 | 625 | 1 084 562 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 25 000 | 8 676 492 | 0,29 | 0,13 | 3 250 | 1 127 944 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 000 | 8 676 492 | 0,06 | 0,13 | 650 | 1 127 944 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 000 | 8 676 492 | 0,06 | 0,12 | 600 | 1 041 179 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 000 | 8 676 492 | 0,06 | 0,12 | 600 | 1 041 179 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 30 000 | 8 676 492 | 0,35 | 0,15 | 4 500 | 1 301 474 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 8 300 | 8 676 492 | 0,10 | 0,15 | 1 245 | 1 301 474 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 1 700 | 8 676 492 | 0,02 | 0,15 | 254 | 1 295 400 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 20 000 | 8 676 492 | 0,23 | 0,15 | 3 000 | 1 301 474 | |
2018-04-02 |
|
5 | imun |
Immune Therapeutics, Inc.
common |
P - Purchase | 5 000 | 8 676 492 | 0,06 | 0,15 | 750 | 1 301 474 |